Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 38(Granted Patents)

Location History:

Mishima, JP (1991)
Osaka, JP (1991 - 1992)
Hyogo-ken, JP (1998)
Takarazuka, JP (1996 - 2012)

Company Filing History:

Nippon Soda Co., Ltd.

patents

1 out of 23

Daiichi Suntory Pharma Co., Ltd.

patents

4. 1 out of 1,309

Japan Science and Technology Agency

Nagoya City University

patents

where one patent can have more than one assignee

Years Active: 1991-2012

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8318781 - G-protein-conjugated receptor agonist (2012-11-27),

2. 6867297 - Process for synthesizing 4-substituted azetidinone derivatives (2005-03-15),

3. 6051569 - 1'S, 5R, 6R-carbapenem derivatives and antimicrobial agents comprising (2000-04-18),

4. 6049009 - Production method of optically active trans-vinylsulfide alcohol (2000-04-11),

5. 5885981 - Antibacterial penem esters derivatives (1999-03-23),

6. 5830889 - Antibacterial penem esters derivatives (1998-11-03),

7. 5821362 - Method of desilylating silylether compounds (1998-10-13),

8. 5703068 - Penem compounds (1997-12-30),

9. 5506225 - Antibacterial penem compounds (1996-04-09),

10. 5116832 - Penem derivatives production and use thereof (1992-05-26),

11. 5026844 - Process for the preparation of 4-acyloxy-2-azetidinone derivatives (1991-06-25),

12. 4997829 - Penem compounds, and use thereof (1991-03-05),

13. 4985575 - Process for preparing optically active tetrahydro-2-furoic acid (1991-01-15),

Title: Masaji Ishiguro: Innovator in Pharmaceutical Chemistry

Introduction

Masaji Ishiguro is a prominent inventor based in Takarazuka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 13 patents. His work focuses on developing novel compounds with therapeutic applications.

Latest Patents

One of his latest patents involves a G-protein-conjugated receptor agonist. This patent discloses a novel aralkyl carboxylic acid compound that exhibits agonistic activity on GPR-120 and/or GPR-40. This compound is particularly useful as an appetite regulator, an anti-obesity agent, and a therapeutic agent for various conditions, including diabetes and metabolic syndrome. Another recent patent details a process for synthesizing 4-substituted azetidinone derivatives, which involves reacting specific azetidinone derivatives with ester compounds in the presence of zinc and copper compounds.

Career Highlights

Throughout his career, Masaji Ishiguro has worked with notable companies such as Suntory Limited and Nippon Soda Co., Ltd. His innovative approaches have led to advancements in drug development and therapeutic solutions.

Collaborations

Masaji Ishiguro has collaborated with esteemed colleagues, including Takashi Nakatsuka and Hiromitsu Iwata. These partnerships have further enhanced his research and development efforts.

Conclusion

Masaji Ishiguro's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a leading inventor in the field. His work continues to impact the development of therapeutic agents for various health conditions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.